Stada Arzneimittel Q2 Net Profit Up 9%

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Stada Arzneimittel AG (OTC: STDAF) reported a 9% rise in its second-quarter net profit. Stada Arzneimittel's quarterly sales climbed to EUR441.9 million ($547.7 million), versus EUR411.4 million, in the year-ago period. However, analysts were expecting revenue of EUR447 million. Its net profit climbed to EUR28.7 million, versus analysts' estimates of EUR31 million.Stada Arzneimittel's sales in the Asia-Pacific region jumped 54% y/y to EUR33.2 million in the first half, while sales in western Europe gained 3% to EUR595.5 million.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!